Art

J-GLOBAL ID：201402296060569493   Reference number：14A1289379

Severe Immune Thrombocytopenia Possibly Elicited by the Anti-influenza Viral Agent Peramivir

抗インフルエンザウイルス剤ペラミビルに誘発されたと思われる重度の免疫性血小板減少症

Author (13)： HARADA-SHIRADO Kayo (Dep. of Cardiology and Hematology, Fukushima Medical Univ., JPN) ,  IKEDA Kazuhiko (Dep. of Cardiology and Hematology, Fukushima Medical Univ., JPN) ,  FURUKAWA Miki (Dep. of Cardiology and Hematology, Fukushima Medical Univ., JPN) ,  SUKEGAWA Masumi (Dep. of Cardiology and Hematology, Fukushima Medical Univ., JPN) ,  TAKAHASHI Hiroshi (Dep. of Cardiology and Hematology, Fukushima Medical Univ., JPN) ,  SHICHISHIMA-NAKAMURA Akiko (Dep. of Cardiology and Hematology, Fukushima Medical Univ., JPN) ,  OHKAWARA Hiroshi (Dep. of Cardiology and Hematology, Fukushima Medical Univ., JPN) ,  NOJI Hideyoshi (Dep. of Cardiology and Hematology, Fukushima Medical Univ., JPN) ,  KAWABATA Kinuyo (Dep. of Blood Transfusion and Transplantation Immunology, Fukushima Medical Univ., JPN) ,  SAITO Shun-ichi (Dep. of Blood Transfusion and Transplantation Immunology, Fukushima Medical Univ., JPN) ,  OHTO Hitoshi (Dep. of Blood Transfusion and Transplantation Immunology, Fukushima Medical Univ., JPN) ,  OGAWA Kazuei (Dep. of Cardiology and Hematology, Fukushima Medical Univ., JPN) ,  TAKEISHI Yasuchika (Dep. of Cardiology and Hematology, Fukushima Medical Univ., JPN)
Material： Internal Medicine (Web)  (Intern Med (Web))
Volume： 53  Issue： 20  Page： 2369-2371 (J-STAGE)  Publication year： 2014 
JST Material Number： U0033A  ISSN： 1349-7235  Document type： Article
Article type： 短報  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *Immune thrombocytopenia ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A1289379&from=J-GLOBAL&jstjournalNo=U0033A") }}

JST classification (2)： Hematologic diseases  (GK03000F) ,  Treatment for infectious diseases,parasitic diseases.  (GD01030D)

Substance index (2)： RWJ-270201 ,  Prednisolone

Reference (18)：

• 1. Birnkrant D, Cox E. The emergency use authorization of peramivir for treatment of 2009 H1N1 influenza. N Engl J Med 361: 2204-2207, 2010.
• 2. Kohno S, Yen MY, Cheong HJ, Hirotsu N. Single-intravenous peramivir vs. oral oseltamivir to treat acute, uncomplicated influenza in the outpatient setting: a phase III, randomized, double-blind trial [abstract]. V-537a. 49th Interscience. Conference. on Antimicrobial. Agents Chemotherapy, 2009.
• 3. Hu Y, Lu S, Song Z, et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 381: 2273-2279, 2013.
• 4. Background and summary of human infection with influenza A (H7N9) virus- as of 5 April 2013. Available from: http://www.who.int/influenza/human_animal_interface/latest_update_h7n9/en/index.html
• 5. Kohno S, Kida H, Mizuguchi M, et al. Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients. Antimicrob Agents Chemother 55: 2803-2812, 2011.

Terms in the title (4)： 抗インフルエンザウイルス剤 ,  ペラミビル ,  誘発 ,  免疫性血小板減少症